🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2, open-label, multicenter, 2-arm study of bosutinib admini...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-02
Trial ID
NCT00793546
Treatments Being Tested
Study comparing 2 formulations of bosutinib in healthy subjects....
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-02
Trial ID
NCT01080365
Treatments Being Tested
The purpose of this study is to describe the efficacy and safety of bosutin...
Status
Completed
Location
Royal Liverpool Hospital
Start Date
2015-07-15
Trial ID
NCT02546375
Treatments Being Tested
The purpose of this study is to see if there is an effect on the pharmacoki...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-08
Trial ID
NCT00952913
Treatments Being Tested
The combination of bosutinib plus atezolizumab in first line treatment in n...
Status
Terminated
Location
Hospital Universitario Ramón y Cajal
Start Date
2021-02-24
Trial ID
NCT04793399
Treatments Being Tested
This study evaluates the effect of Bosutinib (Bosulif,Pfizer®) in the treat...
Status
Completed
Location
MedStar Georgetown University Hospital
Start Date
2019-04-23
Trial ID
NCT03888222
Treatments Being Tested
The purpose of this study is to fulfill the post-authorization commitment m...
Status
Terminated
Location
Keck Hospital of USC
Start Date
2014-11-07
Trial ID
NCT02228382
Treatments Being Tested
Two-arm, randomized, open-label trial designed to evaluate the efficacy and...
Status
Completed
Location
Pacific Cancer Medical Center Inc
Start Date
2008-02-05
Trial ID
NCT00574873
This study will address the therapeutic activity and the safety/biological ...
Status
Unknown
Location
Presidio Ospedaliero "Oncologico Businco" - Cagliari (CA)
Start Date
2021-02-01
Trial ID
NCT04709731
Treatments Being Tested
This is a phase 2 study of bosutinib administered in combination with letro...
Status
Terminated
Location
American Institute of Research
Start Date
2009-07-30
Trial ID
NCT00880009